BackEledon Pharmaceuticals Overview

Eledon Pharmaceuticals Receivables

Track Eledon Pharmaceuticals's receivables ($580K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$583000.00

Peer average

Loading

Eledon Pharmaceuticals Receivables History

Loading

Eledon Pharmaceuticals vs. peers: Receivables Comparison

Loading

Eledon Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Eledon Pharmaceuticals (ELDN) FAQ

Eledon Pharmaceuticals (ELDN) currently reports a receivables of $580K as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Eledon Pharmaceuticals's receivables history and peer comparisons.

Eledon Pharmaceuticals's receivables changed from $0 to $580K (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Eledon Pharmaceuticals reported $580K in receivables as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $580K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Eledon Pharmaceuticals, and consider following ELDN for alerts when major investors trade the stock.

Eledon Pharmaceuticals is classified in the Healthcare sector. On receivables, it currently shows $580K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ELDN with unrelated industries.